FLT3 and acute myeloid leukemia: The mechanism of primary intrinsic resistance to FLT3 inhibitors is the lack of dependency of AML with FLT3 mutations to FLT3 signaling due to the coexistence of numerous leukemic clones and low allelic cells of the FLT3 mutation [72].